Edition:
United States

Cardlytics Inc (CDLX.OQ)

CDLX.OQ on NASDAQ Stock Exchange Global Market

13.53USD
14 Dec 2018
Change (% chg)

$0.61 (+4.72%)
Prev Close
$12.92
Open
$12.66
Day's High
$13.92
Day's Low
$12.58
Volume
56,610
Avg. Vol
57,798
52-wk High
$28.23
52-wk Low
$11.10

Latest Key Developments (Source: Significant Developments)

Cardlytics Q3 Non-GAAP Loss Per Share $0.15
Tuesday, 13 Nov 2018 04:05pm EST 

Cardlytics Inc ::CARDLYTICS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 GAAP LOSS PER SHARE $0.40.Q3 REVENUE $34.6 MILLION VERSUS I/B/E/S VIEW $37.6 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.51 -- THOMSON REUTERS I/B/E/S.Q3 NON-GAAP LOSS PER SHARE $0.15.QTRLY CARDLYTICS DIRECT REVENUE WAS $34.4 MILLION, AN INCREASE OF 14%, COMPARED TO $30.2 MILLION IN Q3 OF 2017.SEES FY 2018 REVENUE IN THE RANGE OF $146.0 MILLION - $148.0 MILLION.SEES Q4 2018 REVENUE $43.0 MILLION - $45.0 MILLION.SEES Q4 2018 REVENUE IN THE RANGE OF $43.0 MILLION - $45.0 MILLION.SEES 2018 REVENUE $146.0 MILLION - $148.0 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $20.1.SEES Q4 2018 NON-GAAP EARNINGS PER SHARE $21.4.  Full Article

Cardlytics Reports Q4 GAAP Loss Per Share of $1.26
Monday, 19 Mar 2018 04:01pm EDT 

March 19 (Reuters) - Cardlytics Inc ::CARDLYTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 GAAP LOSS PER SHARE $1.26.Q4 REVENUE $39.3 MILLION VERSUS I/B/E/S VIEW $38.6 MILLION.Q4 EARNINGS PER SHARE VIEW $-0.56 -- THOMSON REUTERS I/B/E/S.Q4 NON-GAAP LOSS PER SHARE $0.18.FI MAUS WERE 58.7 MILLION IN Q4 OF 2017, AN INCREASE OF 24%.ARPU WAS $0.66 IN Q4 OF 2017 COMPARED TO $0.67 IN Q4 OF 2016.  Full Article

Cardlytics Announces Pricing Of Initial Public Offering
Thursday, 8 Feb 2018 06:40pm EST 

Feb 8 (Reuters) - Cardlytics Inc ::CARDLYTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 5.40 MILLION COMMON SHARES PRICED AT $13.00PER SHARE.  Full Article